Allegis Corporation Producing Face Shields at Illinois Subsidiary
According to company officials, through its newly acquired flexible products division located in the Chicago area, Allegis is building protective face shields for workers who require protection while working in the manufacturing and processing sectors of the economy.
Based on demand for Allegis’ face shields, the company is presently making 500 face shields per day at Libertyville, Illinois based Rhopac Products, which it acquired in October 2019. Allegis, deemed an essential business during the Covid-19 crisis, has received orders for the face shields from numerous manufacturers, including Fortune 500 companies. The company said it intends to increase production considering the need for face shields by its customers for the foreseeable future. The Allegis face shield is made entirely in the USA with components sourced from U.S. suppliers.
“If we’re going to get our country moving again,” said Clayton Keister, CEO of Allegis Corporation, “we all need to be nimble and ready to adapt quickly to change.”
“We’re not a face shield or a PPE manufacturer,” said Keister, “but when our customers learned we could make a quality shield with very little lead time and do it all right here in the U.S., they immediately responded. I’m proud of our team and their can-do spirit in getting America back to work.”
At the request of a long-standing customer, Genie, a Terex brand, Allegis designed and produced enough materials to build an initial 5,000 face shields for Overlake Medical Center in Bellevue, Washington, in just four business days.
“We pivoted fast to make these face shields for our customer,” said Rick Frank, Allegis Director of Sales. “We mustered our expertise in engineering and design, sourcing and manufacturing to produce these face shields for the doctors, nurses and other frontline workers at Overlake Medical Center.”
“While the Covid-19 pandemic continues to unfold with no clear sight as to when it will be defeated, business leaders and workers alike want to get back to work and return the U.S. economy back to where it was before the pandemic hit, company officials said.
The company said its 140 employees, many of whom have been working remotely, have been proactively reaching out to customers to listen carefully to what they need to safely open up their manufacturing and processing plants.
On the Hunt for a Productive New Biomanufacturing Site?
Changes in the Incentives Landscape
Labor Challenges in the Industrial and Manufacturing Sectors Persist
Workforce Q4 2021
Solutions for Decisively Navigating the Location Decision
Location Factors for Cell and Gene Therapy Companies
The Challenges of Renovating an Existing Facility Into a Food Plant